121 related articles for article (PubMed ID: 2690315)
1. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
Veyrac M; Ribard D; Daures JP; Mion H; Lequellec A; Martinez J; Bataille D; Michel H
Scand J Gastroenterol; 1989 Dec; 24(10):1238-42. PubMed ID: 2690315
[TBL] [Abstract][Full Text] [Related]
2. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretion.
Dubrasquet JM; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():257-9. PubMed ID: 2875447
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
Jarrousse C; Niel H; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():253-6. PubMed ID: 3748850
[TBL] [Abstract][Full Text] [Related]
5. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
Dubrasquet M; Bataille D; Gespach C
Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
[No Abstract] [Full Text] [Related]
7. Synthesis of the C-terminal octapeptide of pig oxyntomodulin. Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala: a potent inhibitor of pentagastrin-induced acid secretion.
Audousset-Puech MP; Jarrousse C; Dubrasquet M; Aumelas A; Castro B; Bataille D; Martinez J
J Med Chem; 1985 Oct; 28(10):1529-33. PubMed ID: 4045927
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat.
Jarrousse C; Carles-Bonnet C; Niel H; Sabatier R; Audousset-Puech MP; Blache P; Kervran A; Martinez J; Bataille D
Am J Physiol; 1993 May; 264(5 Pt 1):G816-23. PubMed ID: 8498507
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Rolland M; Bataille D
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):57-63. PubMed ID: 1538791
[TBL] [Abstract][Full Text] [Related]
11. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
Biedzinski TM; Bataille D; Devaux MA; Sarles H
Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
[TBL] [Abstract][Full Text] [Related]
12. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Bataille D
Eur J Pharmacol; 1991 Oct; 203(2):245-52. PubMed ID: 1800120
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man.
O'Halloran DJ; Nikou GC; Kreymann B; Ghatei MA; Bloom SR
J Endocrinol; 1990 Jul; 126(1):169-73. PubMed ID: 2380653
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
[TBL] [Abstract][Full Text] [Related]
15. The stability of gastric acid secretion during prolonged pentagastrin stimulation in man.
Petersen B; Christiansen J; Kirkegaard P; Olsen PS
Clin Sci (Lond); 1984 Jan; 66(1):99-101. PubMed ID: 6690196
[TBL] [Abstract][Full Text] [Related]
16. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
17. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
[TBL] [Abstract][Full Text] [Related]
18. H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin.
Carles-Bonnet C; Martinez J; Jarrousse C; Aumelas A; Niel H; Bataille D
Peptides; 1996; 17(3):557-61. PubMed ID: 8735987
[TBL] [Abstract][Full Text] [Related]
19. Interaction of glucagon and pentagastrin on pepsin secretion in healthy subjects.
Christiansen J; Holst JJ; Molin J
Gut; 1982 Jun; 23(6):528-31. PubMed ID: 6804315
[TBL] [Abstract][Full Text] [Related]
20. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
